-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Live Q&A

Program: Scientific Workshops @ ASH
Session: Engineered Immune Cells in the Management of Lymphoid Malignancies
Wednesday, December 2, 2020, 8:20 AM-9:55 AM

Jeremy S. Abramson, MD

Massachusetts General Hospital, Boston, MA

Disclosures: No relevant conflicts of interest to declare.